Sanofi (SNY) Net Equity Issued and Repurchased (2010 - 2026)
Sanofi's Net Equity Issued and Repurchased was $11.62 million in the quarter ended Jun 30, 2026, up 46.7% from $7.92 million a year earlier and up 24.1% from the prior quarter.
Sanofi (SNY) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sanofi's Net Equity Issued and Repurchased was $193.97 million through Jun 30, 2026, down 9.0% year-over-year; for the year ended Dec 31, 2025, it came in at $199.98 million, down 1.2% from the prior year.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Net Equity Issued and Repurchased was $202.4 million in the year ended Dec 31, 2024 (-4.0%), $210.93 million in the year ended Dec 31, 2023 (+6.5%), $198.14 million in the year ended Dec 31, 2022 (-10.0%) and $220.11 million in the year ended Dec 31, 2021 (-5.0%).
- Quarterly Net Equity Issued and Repurchased has moved between $7.48 million (the quarter ended Dec 31, 2024) and $174.62 million (the quarter ended Sep 30, 2024) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in five of the last eight quarters, with growth averaging 4.7%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was the quarter ended Jun 30, 2022 (growth of 99.4%); the worst was the quarter ended Mar 31, 2026 (a decline of 59.5%).
- Per Business Quant data, SNY's Net Equity Issued and Repurchased in the three quarters before the quarter ended Jun 30, 2026 was $9.37 million (quarter ended Mar 31, 2026), $8.15 million (quarter ended Dec 31, 2025) and $164.84 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.13 Bn | 1,100.72 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 634.87 Bn | 554.73 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 506.59 Bn | 479.70 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 357.59 Bn | 311.97 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 291.51 Bn | 255.50 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 238.17 Bn | 193.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.18 Bn | 169.37 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn | - |
| 10 | Sanofi | 50.65 Bn | 17.17 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.62 Mn |
| Mar 31, 2026 | 9.37 Mn |
| Dec 31, 2025 | -55.87 Mn |
| Sep 30, 2025 | -56.11 Mn |
| Jun 30, 2025 | -8.61 Bn |
| Mar 31, 2025 | 3.82 Bn |
| Dec 31, 2024 | 330.20 Mn |
| Sep 30, 2024 | 837.94 Mn |
| Jun 30, 2024 | -642.90 Mn |
| Mar 31, 2024 | 343.29 Mn |
| Dec 31, 2023 | 646.64 Mn |
| Sep 30, 2023 | 960.14 Mn |
| Jun 30, 2023 | -774.23 Mn |
| Mar 31, 2023 | 406.80 Mn |
| Jun 30, 2022 | -739.47 Mn |
| Mar 31, 2022 | 418.63 Mn |
| Jun 30, 2021 | -322.74 Mn |
| Mar 31, 2021 | 182.14 Mn |
| Jun 30, 2020 | -788.65 Mn |
| Mar 31, 2020 | 433.85 Mn |
Sanofi Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();